Envista
Provides dental technologies, consumables, and services through a multi-brand portfolio.
$27.00
After-hours close−0.14 (−0.52%)
At close$27.14(−1.09%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 120.67%Insiders 0.87%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 162.73M · Float 162.02M · 99.6% free float
Institutions13F, as of Jun 30, 2026
387 holders · 196.36M shares · 52 new positions · 200 increased · 129 reduced · 61 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 18.44M | 11.33% | +584.7K | Aug 7, 2026 |
| Ariel Investments, LLC | 9.82M | 6.03% | −1.05M | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 9.57M | 5.88% | −214.0K | Aug 11, 2026 |
| Vanguard Portfolio Management LLC | 7.49M | 4.60% | −79.1K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 7.34M | 4.51% | +19.3K | Aug 13, 2026 |
| Morgan Stanley | 6.44M | 3.96% | −2.36M | Aug 13, 2026 |
| Gates Capital Management, Inc. | 5.55M | 3.41% | +189.7K | Aug 14, 2026 |
| State Street Corp | 5.33M | 3.27% | +100.5K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 9.20% | 15.86M | 13G | Apr 17, 2025 ↗ |
| Dimensional Fund Advisors LP | 5.40% | 9.17M | 13G | Jul 15, 2025 ↗ |
| Vanguard Capital Management | 5.23% | 8.57M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Paul A. Keel | director, officer: Chief Executive Officer | 551.3K | 0.34% | Aug 20, 2026 |
| Eric D. Hammes | officer: Chief Financial Officer | 99.9K | 0.06% | Aug 27, 2026 |
| R. Scott Huennekens | director | 82.1K | 0.05% | May 21, 2026 |
| Barbara B. Hulit | director | 79.8K | 0.05% | Jun 12, 2025 |
| Mark E. Nance | officer: General Counsel | 68.6K | 0.04% | Feb 27, 2026 |
| Stefan Nilsson | officer: President, Nobel Biocare | 61.6K | 0.04% | Aug 27, 2026 |
| Wendy Carruthers | director | 59.9K | 0.04% | May 21, 2026 |
| Christine A. Tsingos | director | 59.9K | 0.04% | May 21, 2026 |
| Kieran Gallahue | director | 54.0K | 0.03% | May 21, 2026 |
| Daniel Raskas | director | 54.0K | 0.03% | May 21, 2026 |
12 people have not refiled in the last 18 months (707.6K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 20, 2026 | Mischa Reisofficer: SVP, Strategy & Bus. Dev. | Sale | 8,000 | $27.50 | 27,321 |
| Feb 10, 2026 | Mischa Reisofficer: SVP, Strategy & Bus. Dev. | Sale | 5,634 | $30.00 | 32,382 |
CongressHouse and Senate disclosures
Not reported.